Radioimmunotherapy of refractory non-Hodgkin's lymphoma with 131I-labeled chimeric 81C6 anti-tenascin monoclonal antibody:: Dosimetry study.

被引：0
|
作者：
Akabani, G [1 ]
Rizzieri, D [1 ]
Coleman, RE [1 ]
Metzler, SD [1 ]
Zalutsky, MR [1 ]
Bigner, DD [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC 27706 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2002年 / 43卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1259
引用
收藏
页码：313P / 313P
页数：1
相关论文
共 50 条
  • [31] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [32] Results of a phase I trial of patients with recurrent brain tumors and prior radiation therapy treated with 131I-labeled antitenascin monoclonal antibody 81C6 via surgically created resection cavities
    Cokgor, I
    Akabani, G
    Brown, MT
    Friedman, AH
    Coleman, RE
    Friedman, HS
    Thorstad, WL
    McLendon, RE
    Bigner, SH
    Zhao, XG
    Pegram, CN
    Wikstrand, CJ
    Herndon, JE
    Vick, NA
    Paleologos, N
    Zalutsky, MR
    Bigner, DD
    NEUROLOGY, 1998, 50 (04) : A354 - A354
  • [33] Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement:: A Monte Carlo-based dosimetric analysis
    Song, Hong
    Du, Yong
    Sgouros, George
    Prideaux, Andrew
    Frey, Eric
    Wahl, Richard L.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (01) : 150 - 157
  • [34] Radioimmunotherapy in relapsed or refractory B-cell non-hodgkin's lymphoma with I-131-labeled chimericanti CD20 C2B8 (I-131 rituximab)
    Kang, H. J.
    Park, Y. H.
    Kim, S.
    Cheon, G. J.
    Choi, C. W.
    Lim, S. M.
    Lee, S. S.
    Na, I. I.
    Ryoo, B. Y.
    Yang, S. H.
    Kim, W. S.
    Kim, K. H.
    Bang, S. M.
    Yuh, Y. J.
    Nam, S. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 109
  • [35] A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma
    Dancey, Gairin
    Violet, John
    Malaroda, Alessandra
    Green, Alan J.
    Sharma, Surinder K.
    Francis, Roslyn
    Othman, Shokri
    Parker, Sweta
    Buscombe, John
    Griffin, Natalie
    Chan, Pei-San
    Malhotra, Anmol
    Woodward, Nicholas
    Ramsay, Alan
    Ross, Philip
    Lister, T. Andrew
    Amlot, Peter
    Begent, Richard
    McNamara, Christopher
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7701 - 7710
  • [36] Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results
    Bigner, DD
    Brown, MT
    Friedman, AH
    Coleman, RE
    Akabani, G
    Friedman, HS
    Thorstad, WL
    McLendon, RE
    Bigner, SH
    Zhao, XG
    Pegram, CN
    Wikstrand, CJ
    Herndon, JE
    Vick, NA
    Paleologos, N
    Cokgor, I
    Provenzale, JM
    Zalutsky, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2202 - 2212
  • [37] Preclinical studies on yttrium-90-labeled CDR-grafted monoclonal antibody for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths, GL
    Govindan, SV
    Shih, LB
    Sharkey, RM
    Goldenberg, DM
    Hansen, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 105P - 105P
  • [38] Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
    Luigi Aloj
    Laura D’Ambrosio
    Michela Aurilio
    Anna Morisco
    Ferdinando Frigeri
    Corradina Caraco’
    Francesca Di Gennaro
    Gaetana Capobianco
    Leonardo Giovannoni
    Hans D. Menssen
    Dario Neri
    Antonio Pinto
    Secondo Lastoria
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 867 - 877
  • [39] Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma
    Aloj, Luigi
    D'Ambrosio, Laura
    Aurilio, Michela
    Morisco, Anna
    Frigeri, Ferdinando
    Caraco', Corradina
    Di Gennaro, Francesca
    Capobianco, Gaetana
    Giovannoni, Leonardo
    Menssen, Hans D.
    Neri, Dario
    Pinto, Antonio
    Lastoria, Secondo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 867 - 877
  • [40] Metabolic response of non-Hodgkin's lymphoma to 131I-anti-B1 radioimmunotherapy:: Evaluation with FDG PET
    Torizuka, T
    Zasadny, KR
    Kison, PV
    Rommelfanger, SG
    Kaminski, MS
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (06) : 999 - 1005
12345